Search research articles
Contact Us
Filters
Showing results (31-40 of 173) with videos related to
Page
of 18
Sort By:
Pharmaceuticals (Basel, Switzerland)
|
May 25, 2024
Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective
Naomi Scarano, Chiara Brullo, Francesca Musumeci, et al.
Plos One
|
December 15, 2010
Molecular characterization of c-Abl/c-Src kinase inhibitors targeted against murine tumour progenitor cells that express stem cell markers
Thomas Kruewel, Silvia Schenone, Marco Radi, et al.
Bioorganic & Medicinal Chemistry
|
November 3, 2005
Affinity prediction on A1 adenosine receptor agonists: the chemometric approach
Paola Fossa, Luisa Mosti, Francesco Bondavalli, et al.
European Journal of Medicinal Chemistry
|
May 20, 2025
Approaching Gallium-68 radiopharmaceuticals for tumor diagnosis: a Medicinal Chemist's perspective
Francesca Musumeci, Alessandro Fasce, Marta Falesiedi, et al.
European Journal of Medicinal Chemistry
|
May 5, 2009
Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data
Elena Dreassi, Alessandra Tania Zizzari, Federico Falchi, et al.
Life (Basel, Switzerland)
|
October 27, 2022
Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-<i>d</i>]pyrimidine Tyrosine Kinase Inhibitors
Sofija Jovanović Stojanov, Ana Kostić, Mila Ljujić, et al.
Expert Opinion on Therapeutic Patents
|
July 15, 2017
Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors
Francesca Musumeci, Monica Sanna, Chiara Greco, et al.
Chemmedchem
|
November 29, 2008
C6-unsubstituted pyrazolo[3,4-d]pyrimidines are dual Src/Abl inhibitors effective against imatinib mesylate resistant chronic myeloid leukemia cell lines
Maria Alessandra Santucci, Valentina Corradi, Manuela Mancini, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Alzheimer's Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective
Naomi Scarano, Francesca Musumeci, Beatrice Casini, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 31, 2009
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors
Stefania Olla, Fabrizio Manetti, Emmanuele Crespan, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 173) with videos related to
Sort By:
Page
of 18
Pharmaceuticals (Basel, Switzerland)
|
May 25, 2024
Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective
Naomi Scarano, Chiara Brullo, Francesca Musumeci, et al.
Plos One
|
December 15, 2010
Molecular characterization of c-Abl/c-Src kinase inhibitors targeted against murine tumour progenitor cells that express stem cell markers
Thomas Kruewel, Silvia Schenone, Marco Radi, et al.
Bioorganic & Medicinal Chemistry
|
November 3, 2005
Affinity prediction on A1 adenosine receptor agonists: the chemometric approach
Paola Fossa, Luisa Mosti, Francesco Bondavalli, et al.
European Journal of Medicinal Chemistry
|
May 20, 2025
Approaching Gallium-68 radiopharmaceuticals for tumor diagnosis: a Medicinal Chemist's perspective
Francesca Musumeci, Alessandro Fasce, Marta Falesiedi, et al.
European Journal of Medicinal Chemistry
|
May 5, 2009
Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data
Elena Dreassi, Alessandra Tania Zizzari, Federico Falchi, et al.
Life (Basel, Switzerland)
|
October 27, 2022
Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-<i>d</i>]pyrimidine Tyrosine Kinase Inhibitors
Sofija Jovanović Stojanov, Ana Kostić, Mila Ljujić, et al.
Expert Opinion on Therapeutic Patents
|
July 15, 2017
Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors
Francesca Musumeci, Monica Sanna, Chiara Greco, et al.
Chemmedchem
|
November 29, 2008
C6-unsubstituted pyrazolo[3,4-d]pyrimidines are dual Src/Abl inhibitors effective against imatinib mesylate resistant chronic myeloid leukemia cell lines
Maria Alessandra Santucci, Valentina Corradi, Manuela Mancini, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Alzheimer's Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective
Naomi Scarano, Francesca Musumeci, Beatrice Casini, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 31, 2009
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors
Stefania Olla, Fabrizio Manetti, Emmanuele Crespan, et al.
Page
of 18